P. Johnston
Oncology · with Longley · 2005
A researcher in the Science corpus: 1 paper; trusts 6 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 23 citations into it
- Molecular Biology — 22 citations into it
- Cancer Research — 5 citations into it
Whom P. Johnston trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Lewis C. Cantley (in Molecular Biology)
- Karen H. Vousden (in Molecular Biology)
- Michael O. Hengartner (in Molecular Biology)
- A. Baldwin (in Molecular Biology)
- A. Ashkenazi (in Immunology)
- H. Lane (in Molecular Biology)
Papers from P. Johnston's perspective
Ordered by how strongly the researchers P. Johnston trusts endorse each paper. Same corpus, a different order for every researcher.
- The phosphoinositide 3-kinase pathway. (Science)
- Oncogenic kinase signalling (Nature)
- Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. (Clinical Cancer Research)
- The STATs of cancer — new molecular targets come of age (Nature Reviews. Cancer)
- The protein kinase B/Akt signalling pathway in human malignancy. (Cellular Signalling)
- Role of BAX in the apoptotic response to anticancer agents. (Science)
- The biochemistry of apoptosis (Nature)
- Targeting death and decoy receptors of the tumour-necrosis factor superfamily (Nature Reviews. Cancer)
- NF-κB in cancer: from innocent bystander to major culprit (Nature Reviews. Cancer)
- ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. (Journal of Clinical Oncology)
Their papers
- Molecular mechanisms of drug resistance (2005) — 1,664 citations